Leinco Technologies Funding: How Much Did They Raise & Key Investors

How Much Did Leinco Technologies Raise?
Funding & Key Investors

Leinco Technologies, a biotechnology firm established in 1992, has secured $150K in total capital. The company recently announced a major strategic investment, bringing its recent funding to $150K, underscoring its position in the life sciences sector. This significant financial backing signals a period of accelerated growth and development for the company's innovative research products and services.

What is Leinco Technologies?

Leinco Technologies

Business Services

Research & Development

Manufacturing

Leinco Technologies, Inc. is a specialized manufacturer in the biotechnology field, founded in 1992. The company focuses on producing early discovery research products, including antibodies, recombinant proteins, and ELISA kits. Leinco Technologies also offers custom research and development and manufacturing services, particularly in monoclonal antibodies and recombinant proteins. These offerings are designed to enhance the early stages of life science research, diagnostics, and the development of protein therapeutics.

How much funding has Leinco Technologies raised?

Leinco Technologies has raised a total of $150K across 1 funding round:

2020

Debt

$150K

Debt (2020): $150K with participation from PPP

What's next for Leinco Technologies?

With the recent influx of capital from a major strategic investment, Leinco Technologies is poised for significant expansion. This large-scale, late-stage funding is indicative of the company's maturity and its potential for substantial market impact. The strategic investment will likely fuel advancements in product development, manufacturing capabilities, and market penetration, solidifying Leinco's role as a key player in the biotechnology and life sciences research supply chain.

See full Leinco Technologies company page

See More Financial Insights